European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has launched a new research initiative focused on Klotho, a protein with transformative potential in longevity medicine. Led by Professor Dr. Mike Chan,...
Health In Tech Announces Closing of Initial Public Offering
STUART, Fla., Dec. 25, 2024 /PRNewswire/ -- Health In Tech, an Insurtech platform company backed by third-party AI technology, today announced the closing of its initial public offering of 2,300,000 shares of its Class A common stock at a public...
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS
NANTONG and SUZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I...
Korea Zinc Announces Agenda for the Extraordinary General Meeting, Reinforcing its Commitment to Shareholders
SEOUL, South Korea, Dec. 24, 2024 /PRNewswire/ -- Korea Zinc (KRX:010130) held a special directors meeting on December 23 to finalize the agenda for the extraordinary general meeting (EGM) scheduled for January 23. The meeting focused on measures to...
Arcadium Lithium Announces Shareholder Approval of Proposed Rio Tinto Transaction and Provides Regulatory Update
PHILADELPHIA and PERTH, Australia, Dec. 24, 2024 /PRNewswire/ -- Arcadium Lithium plc (NYSE: ALTM, ASX: LTM, "Arcadium Lithium"), a leading global lithium chemicals producer, today announced that it has obtained all requisite shareholder approvals...
Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis
CHENGDU, China, Dec. 23, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of...
Foxconn Announces Strategic Partnership With Zettabyte to Transform AI Data Centers
TAIPEI, Dec. 23, 2024 /PRNewswire/ -- Zettabyte, a global leader in AI data center software and infrastructure solutions, is proud to announce a strategic partnership with Hon Hai Technology Group (Foxconn), the world's largest electronics...
Miral Announces Ambitious Sustainability Strategy to Advance Responsible Leisure, Entertainment and Tourism
Miral's Sustainability Strategy outlines major initiatives to achieve Miral's goal of becoming the region's benchmark for LET sustainability by 2030 The strategy builds upon a legacy of its ongoing commitment to responsible entertainment. The...
POSCO International announces 'Corporate and Shareholder Value-up Plan' to double shareholder return ratio to 50%
- Expands shareholder return ratio to 50% and adopt interim dividends, aiming to become South Korea's leading shareholder-friendly company - Promote sustainable growth through the expansion of agro and energy business and the advancement of the...
CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody
SHANGHAI, Dec. 23, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, announced today the submission of clinical trial...